Safety and Immunogenicity of the ChAdOx1 nCoV-19 Vaccine Against SARS-CoV-2: a Preliminary Report of a Phase 1/2, Single-Blind, Randomised Controlled Trial
Read the entire article.
Click https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext link to open resource.